Skip to main content

Table 2 Characteristics of the patients obtained from the IMvigor210

From: A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer

Basic information   IMvigor210 (n = 348)
Age Less than 1 year 176
1–2 years 99
More than 2 years 73
Gender Female 76
Male 272
Subtype I & II 213
III & IV 135
Response CR/PR 68
SD/PD 230
NA 50
  1. BC bladder cancer, CR complete response, PR partial response, SD stable disease, PD progressive disease